Characteristic | N = 51 |
---|---|
Age (mean (SD)), years | 11.5 (2.4) |
Gender, n (%) | |
Female | 12 (23.5) |
Missing | 10 (19.6) |
Asthma control at enrollment, (mean (SD)) | |
Uncontrolled (ACT ≤ 19), n (%) | 15 (29.4) |
Controlled (ACT > 19), n (%) | 20 (39.2) |
Missing, n (%) | 16 (31.4) |
Days in program (per SABA syncing) | 290.4 (185.5) |
Month 1 (baseline) SABA usage data | |
Daily SABA use (mean (SD)), puffs/day | 0.68 (1.11) |
Daily SABA use (median(IQR)), puffs/day | 0.27 (0.13, 0.98) |
Weekly SABA use (mean (SD)), puffs/week | 4.79 (7.77) |
Weekly SABA use (median(IQR)), puffs/week | 1.87 (0.93, 6.88) |
SABA-free days (mean (SD)), days | 25.2 (4.8) |
SABA-free days (median(IQR)), days | 27 (22.5, 29) |
Number of SABA medications on hand (patient-reported) | |
1 | 32 (62.7) |
2 | 18 (35.3) |
3 | 1 (2.0) |
Number of followers per patient, mean (SD) | 3.20 (2.2) |
Patients with ≥ 2 followers, n (%) | 35 (68.6) |
Number of patients with a compatible controller inhaler | 9 (17.6) |